What test should be ordered for a patient with recent influenza and pneumonia, presenting with a productive cough, to rule out bacterial superinfection?

Testing for Bacterial Superinfection in Post-Influenza Pneumonia

For a patient with recent influenza presenting with productive cough and pneumonia, order a chest radiograph immediately, followed by blood cultures, sputum Gram stain and culture (if purulent and pre-antibiotic), and pneumococcal/Legionella urine antigens to identify bacterial superinfection. 1

Initial Diagnostic Approach

The diagnostic workup must be stratified by pneumonia severity using the CURB-65 score, as this determines the intensity of microbiological investigation required. 2

Mandatory First-Line Tests (All Patients)

• Chest radiograph: Essential to confirm pneumonia and assess for bilateral involvement, which automatically indicates severe disease requiring hospitalization regardless of other parameters. 1, 2
• Full blood count, urea and electrolytes, liver function tests: Required to assess severity and guide management decisions. 1, 2
• Pulse oximetry: If oxygen saturation <92% on room air, proceed immediately to arterial blood gases. 1, 2
• C-reactive protein: Particularly useful when influenza-related pneumonia is suspected. 1

Microbiological Testing Algorithm

For Severe Pneumonia (CURB-65 Score 3-5 or Bilateral Infiltrates)

Comprehensive bacteriological workup is mandatory: 1

• Blood cultures: Obtain preferably before antibiotic administration, as bacteremia significantly impacts management and prognosis. 1
• Sputum Gram stain, culture, and antimicrobial susceptibility testing: Only if the patient can expectorate purulent samples AND has not received prior antibiotics. Transport rapidly to the laboratory. 1
• Pneumococcal urine antigen (20 ml urine sample): High yield test that remains positive even after antibiotic initiation. 1
• Legionella urine antigen (20 ml urine sample): Important for atypical pathogen coverage. 1
• Tracheal or endotracheal aspirate: If intubated, send for Gram stain, culture, and susceptibility testing. 1

For Non-Severe Pneumonia (CURB-65 Score 0-2)

Microbiological testing is selective: 1

• Sputum Gram stain and culture should be sent only if the patient fails to respond to empirical antibiotic therapy. 1
• This approach is cost-effective and recognizes that routine sputum cultures have limited impact on initial management in stable outpatients. 1

Critical Context: Staphylococcus aureus Risk

In post-influenza pneumonia, empirical antibiotics must cover Staphylococcus aureus, as this is the most common bacterial superinfection pathogen and carries high mortality. 3 The antimicrobial susceptibilities of S. aureus are less predictable than S. pneumoniae or H. influenzae, making culture results particularly valuable if the patient deteriorates or fails initial therapy. 1

Common Pitfalls to Avoid

• Do not delay sputum collection for patients who have already received antibiotics: The yield drops dramatically, making the test unhelpful. 1
• Do not accept oropharyngeal-contaminated samples: Proper sputum collection requires purulent samples free of oral contamination to be clinically useful. 1, 4
• Do not order routine microbiological testing in outpatients with normal vital signs and no radiographic pneumonia: This is not cost-effective and does not change management. 1
• Do not skip blood cultures in severe pneumonia: Even though yield is relatively low, positive results significantly alter antibiotic selection and duration. 1

When Microbiological Testing Changes Management

Microbiological testing should be pursued when results would alter therapy, specifically: 1

• Severe pneumonia requiring hospitalization (always test)
• Failure to respond to empirical antibiotics within 48-72 hours
• Immunocompromised patients
• Suspicion of resistant organisms (recent antibiotic use, healthcare exposure)
• ICU admission or mechanical ventilation

Virology Testing Considerations

Influenza testing is generally not recommended once a pandemic is established, as the diagnosis becomes clinical. 1 However, early in an outbreak or for individual cases, nose and throat swabs in viral transport medium should be obtained if presentation is within 7 days of symptom onset. 1